1958 related articles for article (PubMed ID: 25872541)
21. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
22. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
[TBL] [Abstract][Full Text] [Related]
24. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
[TBL] [Abstract][Full Text] [Related]
25. Roux-en-Y gastric bypass increases hepatic and peripheral insulin sensitivity in rats with type 2 diabetes mellitus.
He B; Chen L; Yu C; Piao D; Wang Y; Han P
Surg Obes Relat Dis; 2014; 10(3):485-93. PubMed ID: 24503104
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
Fatima F; Hjelmesæth J; Birkeland KI; Gulseth HL; Hertel JK; Svanevik M; Sandbu R; Småstuen MC; Hartmann B; Holst JJ; Hofsø D
J Clin Endocrinol Metab; 2022 Jan; 107(2):e756-e766. PubMed ID: 34463768
[TBL] [Abstract][Full Text] [Related]
27. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
Rubino F; Gagner M; Gentileschi P; Kini S; Fukuyama S; Feng J; Diamond E
Ann Surg; 2004 Aug; 240(2):236-42. PubMed ID: 15273546
[TBL] [Abstract][Full Text] [Related]
28. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
[TBL] [Abstract][Full Text] [Related]
29. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
[TBL] [Abstract][Full Text] [Related]
30. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
[TBL] [Abstract][Full Text] [Related]
31. Improved glucose metabolism after gastric bypass: evolution of the paradigm.
Pournaras DJ; Nygren J; Hagström-Toft E; Arner P; le Roux CW; Thorell A
Surg Obes Relat Dis; 2016; 12(8):1457-1465. PubMed ID: 27387696
[TBL] [Abstract][Full Text] [Related]
32. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
33. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
[TBL] [Abstract][Full Text] [Related]
34. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
Meirelles K; Ahmed T; Culnan DM; Lynch CJ; Lang CH; Cooney RN
Ann Surg; 2009 Feb; 249(2):277-85. PubMed ID: 19212182
[TBL] [Abstract][Full Text] [Related]
36. Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.
Svane MS; Toft-Nielsen MB; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S; Bojsen-Møller KN
Diabet Med; 2017 Dec; 34(12):1783-1787. PubMed ID: 28782840
[TBL] [Abstract][Full Text] [Related]
37. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
38. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
39. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
[TBL] [Abstract][Full Text] [Related]
40. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
